The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Abstract
Providing effective care for patients with early stage breast cancer and designing appropriate recommendations for women at high risk of developing the disease are important public health goals. More than ever, progress requires integrated understanding based on the continuous interaction among several scientific and clinical disciplines. In February 1998, the 6th International Conference on Adjuvant Therapy of Primary Breast Cancer was held in St. Gallen, Switzerland. Knowledge of breast cancer genetics, diagnosis, and treatment has evolved since the 5th International Conference that was held in March 1995. At that time, a fundamental theme was to distinguish the role of prognostic factors used in the definition of risk from predictive factors used for the selection of adjuvant treatments according to therapeutic responsiveness ( 1 ). Also at that time, the findings from the 1992 Overview publication ( 2 ) that reported results on ovarian ablation, tamoxifen, and chemotherapy effects were being increasingly applied to justify adjuvant treatment for a wider spectrum of indications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Overgaard, M., Hansen, P. S., Overgaard, J., Rose, C., Andersson, M., Bach, F., Kjaer, M., Gadeberg, C. C., Mouridsen, H. T., Jensen, M.-B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371401 · Cited by 2,554
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Fisher, B., Brown, A., Mamounas, E., Wieand, S., Robidoux, A., Margolese, R. G., Cruz, A. B., Fisher, E. R., Wickerham, D. L., Wolmark, N., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2483 · Cited by 1,801
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
Ragaz, J., Jackson, S. M., Le, N., Plenderleith, I. H., Spinelli, J. J., Basco, V. E., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Paradis, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371402 · Cited by 1,745
Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M., & Christiansen, C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712043372301 · Cited by 1,637
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Fisher, B., Dignam, J., Wolmark, N., Mamounas, E., Costantino, J., Poller, W., Fisher, E. R., Wickerham, D. L., Deutsch, M., Margolese, R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.441 · Cited by 894
Cited by
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Very young women (<35 years) with operable breast cancer: features of disease at presentation
Colleoni, M., Rotmensz, N., Robertson, C., Orlando, L., Viale, G., Renne, G., Luini, A., Veronesi, P., Intra, M., Orecchia, R., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf039 · Cited by 371
Self-citationDepression and degree of acceptance of adjuvant cytotoxic drugs
Colleoni, M., Mandala, M., Peruzzotti, G., Robertson, C., Bredart, A., & Goldhirsch, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02821-x · Cited by 351
Self-citationYoung age: an independent risk factor for disease-free survival in women with operable breast cancer
Han, W., Kim, S. W., Ae Park, I., Kang, D., Kim, S.-W., Youn, Y.-K., Oh, S. K., Choe, K. J., & Noh, D.-Y. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-82 · Cited by 259
Metadata
- Authors
- Goldhirsch, A., Glick, J. H., Gelber, R. D., & Senn, H.-J.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-11-04
- Volume
- 90
- Issue
- 21
- Pages
- 1601-1608
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W4320581625
- Cited by
- 380
- References
- 28
- FWCI
- 13.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. https://app.cochat.ai/papers/10.1093/jnci/90.21.1601
- The paper
- Goldhirsch, A., Glick, J. H., Gelber, R. D., & Senn, H.-J. (1998). Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/90.21.1601
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
